Analysis of Brazil's exports of basic pharmaceutical products and pharmaceutical preparations to Indonesia reveals significant variations in recent years. The data shows a fluctuation in year-on-year export values with notable declines in 2013 and 2014, followed by substantial growth in 2015 and 2017. Over the last two years from 2022 to 2023, the year-on-year export values grew by 3.89%. The compound annual growth rate (CAGR) for the past five years was 3.02%. As of 2023, exports stood at 23.234 million US dollars.

Future forecasts predict continued growth with a forecasted 5-year CAGR of 2.51%, leading to a total growth rate of 13.21% by 2028.

Future Trends to Watch For:

Potential impact of global economic conditions on pharmaceutical demand and supply chains.
Regulatory changes in Indonesia that could affect import policies or drug pricing.
Technological advancements and new product introductions in Brazil's pharmaceutical industry.
Enhanced bilateral trade relations between Brazil and Indonesia, impacting overall export values.